Your browser doesn't support javascript.
loading
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Tanzawa, Shigeru; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Misumi, Toshihiro; Shiraishi, Kenshiro; Matsutani, Noriyuki; Tanaka, Hisashi; Inaba, Megumi; Haruyama, Terunobu; Nakamura, Junya; Kishikawa, Takayuki; Nakashima, Masanao; Iwasa, Keiichi; Fujiwara, Keiichi; Kohyama, Tadashi; Kuyama, Shoichi; Miyazawa, Naoki; Nakamura, Tomomi; Miyawaki, Hiroshi; Ishida, Hiroo; Oda, Naohiro; Ishikawa, Nobuhisa; Morinaga, Ryotaro; Kusaka, Kei; Fujimoto, Nobukazu; Yokoyama, Toshihide; Gemba, Kenichi; Tsuda, Takeshi; Nakagawa, Hideyuki; Ono, Hirotaka; Shimizu, Tetsuo; Nakamura, Morio; Kusumoto, Sojiro; Hayashi, Ryuji; Shirasaki, Hiroki; Ochi, Nobuaki; Aoe, Keisuke; Kanaji, Nobuhiro; Kashiwabara, Kosuke; Inoue, Hiroshi; Seki, Nobuhiko.
Afiliação
  • Tanzawa S; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Itabashi-City, Tokyo, Japan.
  • Ushijima S; Department of Medical Oncology, Kumamoto Chuo Hospital, Kumamoto-City, Kumamoto, Japan.
  • Shibata K; Department of Medical Oncology, Kouseiren Takaoka Hospital, Takaoka-City, Toyama, Japan.
  • Shibayama T; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama-City, Okayama, Japan.
  • Bessho A; Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama-City, Okayama, Japan.
  • Kaira K; Department of Respiratory Medicine, Saitama Medical University International Medical Center, Hidaka-City, Saitama, Japan.
  • Misumi T; Department of Biostatistics, Yokohama City University School of Medicine, Yokohama-City, Kanagawa, Japan.
  • Shiraishi K; Department of Radiology, Teikyo University School of Medicine, Itabashi-City, Tokyo, Japan.
  • Matsutani N; Department of Surgery, Teikyo University Mizonokuchi Hospital, Kawasaki-City, Kanagawa, Japan.
  • Tanaka H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki-City, Aomori, Japan.
  • Inaba M; Department of Respiratory Medicine, Kumamoto Chuo Hospital, Kumamoto-City, Kumamoto, Japan.
  • Haruyama T; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Itabashi-City, Tokyo, Japan.
  • Nakamura J; Department of Respiratory Medicine, Ehime Prefectural Central Hospital, Matsuyama-City, Ehime, Japan.
  • Kishikawa T; Division of Thoracic Oncology, Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya-City, Tochigi, Japan.
  • Nakashima M; Department of Respiratory Medicine, Shin-Yurigaoka General Hospital, Kawasaki-City, Kanagawa, Japan.
  • Iwasa K; Department of Medical Oncology, Kouseiren Takaoka Hospital, Takaoka-City, Toyama, Japan.
  • Fujiwara K; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama-City, Okayama, Japan.
  • Kohyama T; Department of Internal medicine, Teikyo University Mizonokuchi Hospital, Kawasaki-City, Kanagawa, Japan.
  • Kuyama S; Department of Respiratory Medicine, National Hospital Organization Iwakuni Clinical Center, Iwakuni-City, Yamaguchi, Japan.
  • Miyazawa N; Department of Respiratory Medicine, Saiseikai Yokohamashi Nanbu Hospital, Yokohama-City, Kanagawa, Japan.
  • Nakamura T; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga-City, Saga, Japan.
  • Miyawaki H; Department of Respiratory Medicine, Kagawa Prefectural Central Hospital, Takamatsu-City, Kagawa, Japan.
  • Ishida H; Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama-City, Kanagawa, Japan.
  • Oda N; Department of Internal Medicine, Fukuyama City Hospital, Fukuyama-City, Hiroshima, Japan.
  • Ishikawa N; Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima-City, Hiroshima, Japan.
  • Morinaga R; Department of Thoracic Medical Oncology, Oita Prefectural Hospital, Oita-City, Oita, Japan.
  • Kusaka K; The Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Kiyose-City, Tokyo, Japan.
  • Fujimoto N; Department of Medical Oncology, Okayama Rosai Hospital, Okayama-City, Okayama, Japan.
  • Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki-City, Okayama, Japan.
  • Gemba K; Department of Respiratory Medicine, Chugoku Central Hospital, Fukuyama-City, Hiroshima, Japan.
  • Tsuda T; Department of Respiratory Medicine, Toyama Prefectural Central Hospital, Toyama-City, Toyama, Japan.
  • Nakagawa H; Department of Respiratory Medicine, National Hospital Organization, Hirosaki Hospital, Hirosaki-City, Aomori, Japan.
  • Ono H; Department of Respiratory Medicine, Tsuboi Hospital, Koriyama-City, Fukushima, Japan.
  • Shimizu T; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Itabashi-City, Tokyo, Japan.
  • Nakamura M; Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Minato-City, Tokyo, Japan.
  • Kusumoto S; Division of Allergology and Respiratory Medicine, Showa University School of Medicine, Shinagawa-City, Tokyo, Japan.
  • Hayashi R; Clinical Oncology, Toyama University Hospital, Toyama-City, Toyama, Japan.
  • Shirasaki H; Department of Respiratory Medicine, Fukui-ken Saiseikai Hospital, Fukui-City, Fukui, Japan.
  • Ochi N; General Internal Medicine 4, Kawasaki Medical School, Okayama-City, Okayama, Japan.
  • Aoe K; Department of Medical Oncology, National Hospital Organization Yamaguchi-Ube Medical Center, Ube-City, Yamaguchi, Japan.
  • Kanaji N; Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, Kida-gun, Kagawa, Japan.
  • Kashiwabara K; Department of Respiratory Medicine, Kumamoto Regional Medical Center, Kumamoto-City, Kumamoto, Japan.
  • Inoue H; Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu-City, Saga, Japan.
  • Seki N; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8606, Japan.
Ther Adv Med Oncol ; 13: 1758835921998588, 2021.
Article em En | MEDLINE | ID: mdl-33717228
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão